Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M2,130Revenue $M274Net Margin (%)34.2Z-Score32.1
Enterprise Value $M1,873EPS $1.6Operating Margin %52.7F-Score7
P/E(ttm))17.5Cash Flow Per Share $0.4Pre-tax Margin (%)53.1Higher ROA y-yY
Price/Book5.610-y EBITDA Growth Rate %0Quick Ratio6.8Cash flow > EarningsN
Price/Sales6.05-y EBITDA Growth Rate %29.2Current Ratio7.7Lower Leverage y-yY
Price/Cash Flow14.2y-y EBITDA Growth Rate %468ROA % (ttm)36.7Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)3ROE % (ttm)41.8Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M35.8ROI % (ttm)8.9Gross Margin Increase y-yY

Gurus Latest Trades with LCI

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
LCIJoel Greenblatt 2014-12-31 Add0.25%$40.3 - $57.52
($46.48)
$ 59.5022%Add 238.24%1,026,029
LCIJoel Greenblatt 2014-09-30 Add0.12%$34.05 - $51.19
($39.77)
$ 59.5033%Add 749.49%303,345
LCIJoel Greenblatt 2014-06-30 Buy 0.02%$29.62 - $49.76
($39.16)
$ 59.5034%New holding35,709
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

LCI is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


LCI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BEDROSIAN ARTHUR PCEO 2015-04-15Sell5,000$69.43-12.59view
Schreck WilliamCOO 2015-03-16Sell134,635$64.99-6.62view
BEDROSIAN ARTHUR PCEO 2015-03-16Sell5,000$65.23-6.96view
Schreck WilliamCOO 2015-03-12Sell16,177$65.1-6.77view
Taveira PaulDirector 2015-03-06Sell2,500$63.07-3.77view
Schreck WilliamCOO 2015-03-06Sell50,000$63.35-4.2view
Drabik David ADirector 2015-02-18Sell12,500$61.55-1.4view
BEDROSIAN ARTHUR PCEO 2015-02-17Sell5,000$59.891.34view
Landis G. MichaelPrincipal Accounting Officer 2015-02-17Sell11,500$58.63.57view
FARBER JEFFREYDirector 2015-02-13Sell35,000$58.184.31view

Press Releases about LCI :

    Quarterly/Annual Reports about LCI:

    News about LCI:

    Articles On GuruFocus.com
    misc Apr 18 2015 
    Pharmaceutical Stock Picks For March Mar 04 2015 
    My Stocks Feb 13 2015 
    My Stocks Feb 13 2015 
    Lannett Company Looks Cheap At First Glance; But It Is Actually Much Cheaper Than It Looks Dec 29 2014 
    comment on LCI Nov 19 2012 
    comment on LCI Nov 13 2012 
    comment on LCI Jan 26 2012 
    comment on LCI Jan 26 2012 
    comment on LCI Jan 23 2012 

    More From Other Websites
    Lannett To Report Fiscal 2015 Third-Quarter Financial Results And Host Conference Call On Wednesday,... Apr 30 2015
    3 Mid-Cap Pharmaceutical Companies to Add to Your Portfolio Apr 28 2015
    LANNETT CO INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct... Apr 24 2015
    Lannett Expands Revolving Credit Facility To $120 Million Apr 24 2015
    Stop Worrying About A Correction And Do This Apr 22 2015
    Akorn Leads Top Generic-Drug Stocks, Nears Buy Point Apr 20 2015
    IBD Market Wrap - 04/17/15 Apr 17 2015
    Shire's Lialda, Gattex Patents Challenged by Hayman Capital - Analyst Blog Apr 07 2015
    Lannett to Present at the 14th Annual Needham Healthcare Conference on April 14th Apr 07 2015
    Astellas-Medivation's Xtandi Meets Primary Endpoint - Analyst Blog Apr 06 2015
    SAGE Therapeutics' Lead Candidate to Enter Phase III Study - Analyst Blog Apr 06 2015
    Nektar Gets Movantik Milestone Payment from AstraZeneca - Analyst Blog Apr 06 2015
    BIND Extends Collaboration with Pfizer to Develop Accurins - Analyst Blog Apr 06 2015
    LANNETT CO INC Files SEC form 8-K/A, Amendments to Articles of Inc. or Bylaws; Change in Fiscal... Apr 03 2015
    The Medicines Co. Settles Angiomax Patent Dispute with Sun - Analyst Blog Apr 02 2015
    Corcept's Warrants Exercised, Invest in Korlym, Pipeline - Analyst Blog Apr 02 2015
    UCB to Sell Indian Established Brands Portfolio to Dr. Reddy's - Analyst Blog Apr 02 2015
    The Zacks Analyst Blog Highlights: Hewlett-Packard, Aruba Networks, Lannett, Mallinckrodt and Avago... Apr 02 2015
    Genocea Biosciences (GNCA) Crumbles: Stock Falls by 5.6% - Tale of the Tape Apr 02 2015
    Merck Inks Deal with Syndax for Cancer Combo Therapy - Analyst Blog Apr 01 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK